CCAR2 and neoplasm: This study aims to systematically evaluate the prognostic and clinicopathological implications of DBC1 expression across multiple human cancer types, focusing specifically on studies assessing DBC1 in primary tumor tissues and reporting quantifiable survival outcomes or pathological parameters.